Risk factors for invasive fungal disease in critically ill adult patients: a systematic review
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Introduction: Over 5,000 cases of invasive Candida species infections occur in the United Kingdom each year, and around 40% of these cases occur in critical care units. Invasive fungal disease (IFD) in critically ill patients is associated with increased morbidity and mortality at a cost to both the individual and the National Health Service. In this paper, we report the results of a systematic review performed to identify and summarise the important risk factors derived from published multivariable analyses, risk prediction models and clinical decision rules for IFD in critically ill adult patients to inform the primary data collection for the Fungal Infection Risk Evaluation Study. Methods: An internet search was performed to identify articles which investigated risk factors, risk prediction models or clinical decisions rules for IFD in critically ill adult patients. Eligible articles were identified in a staged process and were assessed by two investigators independently. The methodological quality of the reporting of the eligible articles was assessed using a set of questions addressing both general and statistical methodologies. Results: Thirteen articles met the inclusion criteria, of which eight articles examined risk factors, four developed a risk prediction model or clinical decision rule and one evaluated a clinical decision rule. Studies varied in terms of objectives, risk factors, definitions and outcomes. The following risk factors were found in multiple studies to be significantly associated with IFD: surgery, total parenteral nutrition, fungal colonisation, renal replacement therapy, infection and/or sepsis, mechanical ventilation, diabetes, and Acute Physiology and Chronic Health Evaluation II (APACHE II) or APACHE III score. Several other risk factors were also found to be statistically significant in single studies only. Risk factor selection process and modelling strategy also varied across studies, and sample sizes were inadequate for obtaining reliable estimates. Conclusions: This review shows a number of risk factors to be significantly associated with the development of IFD in critically ill adults. Methodological limitations were identified in the design and conduct of studies in this area, and caution should be used in their interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“The majority of IFD in the critical care setting is due to Candida species [2,3].”
BackgroundAttributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798 · cited 11×
“Seven studies [26,27,30,32-36] examined renal replacement therapy as a risk factor for IFD, of which five [26,27,30,32,34,35] found a significant association on univariable analysis.”
BackgroundResultInfluentialBlumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661
León, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · cited 1×
“…1999 [34] 20 > 21 < 1 x ✓ ✓ Chow et al., 2008 [30] 67a 79b 35 1.9a 2.3b x ✓ ✓ Ibàñez-Nolla et al., 2004 [31] 120 30 < 4 x ✓ ✓ Jordà-Marcos et al., 2007 [26] 63 15 4.2 x ✓ ✓ León et al., 2006 [27] 97 22 4.4 x ✓ ✓ Michalopoulos et al., 2003 [36] 30 29 1.0 x ✓ ✓ McKinnon et al., 2001 [32] 27 23 1.2 x…”
InfluentialFluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
Eggimann, P., Francioli, P., Bille, J., Schneider, R., Wu, M.-M., Chapuis, G., Chiolero, R., Pannatier, A., Schilling, J., Geroulanos, S., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199906000-00019 · Cited by 414
Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369
Reporting methods in studies developing prognostic models in cancer: a review
Mallett, S., Royston, P., Dutton, S., Waters, R., & Altman, D. G. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-20 · Cited by 206 · cited 2×
“Adequacy of sample size was established using the generally held rule of ten events per variable [25].”
MethodSandven, P., Qvist, H., Skovlund, E., & Giercksky, K. E. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00008 · Cited by 201
Research works printed but not linked: 27
- Kauffman CA: Fungal infections. Proc Am Thorac Soc 2006, 3: 35-40. 10.1513/pats.200510-110JH · DOI · Paper page
- Health Protection Agency (HPA):Fungal Diseases in the UK: The Current Provision of Support for Diagnosis and Treatment: Assessment and Proposed Network Solution. Report of a working group of the HPA Advisory Committee for Fungal Infection and Superficial Parasites. London: Health Protection Agency; 2006. [http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1196942156347]
- Pittet D, Li N, Woolson RF, Wenzel RP: Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997, 24: 1068-1078. 10.1086/513640 · DOI · Paper page
- Jacobs S, Price Evans DA, Tariq M, Al Omar NF: Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 2003, 31: 1938-1946. 10.1097/01.CCM.0000074724.71242.88 · DOI · Paper page
- Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D: Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002, 28: 1708-1717. 10.1007/s00134-002-1540-y · DOI · Paper page
- Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001, 233: 542-548. 10.1097/00000658-200104000-00010 · DOI · Paper page
- ARDS Network: Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA 2000, 283: 1995-2002. 10.1001/jama.283.15.1995 · DOI · Paper page
- Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L: Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994, 36: 20-26. 10.1097/00005373-199401000-00004 · DOI · Paper page
- Yu M, Tomasa G: A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993, 21: 1635-1642. 10.1097/00003246-199311000-00010 · DOI · Paper page
- Slotman GJ, Burchard KW: Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 1987, 122: 147-151. 10.1001/archsurg.1987.01400140029002 · DOI · Paper page
- Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2006,2006(1):CD004920.
- Playford EG, Webster AC, Sorrell TC, Craig JC: Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006, 57: 628-638. 10.1093/jac/dki491 · DOI · Paper page
- Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME: Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006, 34: 1216-1224. 10.1097/01.CCM.0000208357.05675.C3 · DOI · Paper page
- Ho KM, Lipman J, Dobb GJ, Webb SA: The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis. Crit Care 2005, 9: R710-R717. 10.1186/cc3883 · DOI · Paper page
- Cruciani M, de Lalla F, Mengoli C: Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005, 31: 1479-1487. 10.1007/s00134-005-2794-y · DOI
- Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH: Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005, 33: 1928-1936. 10.1097/01.CCM.0000178352.14703.49 · DOI · Paper page
- Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
- Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C, EPCAN Study Group: Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007, 50: 302-310. 10.1111/j.1439-0507.2007.01366.x · DOI · Paper page
- Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C: Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008, 40: 145-153. 10.1080/00365540701534509 · DOI · Paper page
- Ibàñez-Nolla J, Nolla-Salas M, León MA, García F, Marrugat J, Soria G, Díaz RM, Torres-Rodríguez JM: Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 2004, 48: 181-192. 10.1016/S0163-4453(03)00120-8 · DOI
- McKinnon PS, Goff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ, Mosenthal AC, Gore P, Ambegaonkar AJ, Lubowski TJ: Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001, 136: 1401-1408. 10.1001/archsurg.136.12.1401 · DOI · Paper page
- Borzotta AP, Beardsley K: Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999, 134: 657-664. 10.1001/archsurg.134.6.657 · DOI · Paper page
- Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004, 32: 2443-2449. 10.1097/01.CCM.0000147726.62304.7F · DOI · Paper page
- Steyerberg EW, Eijkemans MJ, Habbema JD: Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999, 52: 935-942. 10.1016/S0895-4356(99)00103-1 · DOI · Paper page
- León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, Cava Study Group: Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37: 1624-1633. 10.1097/CCM.0b013e31819daa14 · DOI · Paper page
- Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC: Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 2009, 35: 2141-2145. 10.1007/s00134-009-1619-9 · DOI
- Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC: Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 2011, 15: R198. 10.1186/cc10366 · DOI · Paper page
Cited by
The Changing Epidemiology of Invasive Fungal Infections
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6515-1_2 · Cited by 370
Candida sp. Infections in Patients with Diabetes Mellitus
Rodrigues, C., Rodrigues, M., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010076 · Cited by 315
Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00872-6 · Cited by 152
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
“ Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier”
Basmaciyan, L., Bon, F., Paradis, T., Lapaquette, P., & Dalle, F. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1612661 · Cited by 89
Metadata
- Authors
- Muskett, H., Shahin, J., Eyres, G., Harvey, S., Rowan, K., & Harrison, D.
- Venue
- Critical Care
- Published
- 2011-11-29
- Volume
- 15
- Issue
- 6
- Pages
- R287-R287
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2100572225
- Cited by
- 150
- References
- 15
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. https://app.cochat.ai/papers/10.1186/cc10574
- The paper
- Muskett, H., Shahin, J., Eyres, G., Harvey, S., Rowan, K., & Harrison, D. (2011). Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Critical Care. https://doi.org/10.1186/cc10574
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.